medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2008, Number 05

<< Back Next >>

Ginecol Obstet Mex 2008; 76 (05)

Gestational malaria: HELLP syndrome mistaken diagnosis

Castillo MNM, Velázquez FJ, Hernández PJA, Acevedo TJL

Language: Spanish
References: 16
Page: 287-291
PDF size: 193.45 Kb.


ABSTRACT

Malaria is one of the most important parasitic infections in Mexico and Latin America. Here we report a case of a 21 year-old female with 38.4 weeks of pregnancy and previous hospitalization due to malaria. Showing a thick drop negative test she was referred to Mexico City Hospital de la Mujer with presumptive diagnosis of preeclampsia and HELLP syndrome. During her stay in ICU she developed malarial paroxysm and Plasmodium vivax was identified, conducting to specific therapy.


REFERENCES

  1. Nosten F, McGready R, Mutabingwa T. Case management of malaria in pregnancy. Lancet Infect Dis 2007;7(2):118-25.

  2. World Health Organization. Roll back malaria, a global partnership. 2002. Disponible en internet en la URL: http://www.rbm.who.int/

  3. Menendez C. Malaria during pregnancy: a priority area of malaria research and control. Parasitol Today 1995;11(5):178-83.

  4. Pan American Health Organization. Regional office of the World Health Organization. Malaria en México: Time Series Epidemiological Data from 1998 to 2004. Disponible en internet en la URL: http://www.paho.org/English/AD/DPC/mal-2005-mex

  5. Piñeros G, Blair S. Malaria y embarazo. Infectio 2002;6(3):168-76.

  6. ACOG Committee on Practice Bulletin–Obstetrics. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002;99(1):159-67.

  7. Diagne N, Rogier C, Sokhna C, Tall A, et al. Increased susceptibility to malaria during the early postpartum period. N Engl J Med 2000;343(9):598-603.

  8. Dellicour S, Hall S, Chandramohan D, Greenwood B. The safety of artemisinins during pregnancy: a pressing question. Malaria J 2007;6:15.

  9. Contreras-Ochoa C, Ramsey JM. Gametocitos de Plasmodium vivax y Plasmodium falciparum: etapas relegadas en el desarrollo de vacunas. Salud Publica Mex 2004;46(1):64-70.

  10. Malagón F. El origen del paroxismo malárico. Rev Med IMSS 2005;43(1):83-88.

  11. Mandell Benet & Dolin. Principles and practice of infectious disease. 6th ed. Philadelphia: Elsevier, 2005;p:9.

  12. Brito BB, Castro GC, Vidal GV. Síndrome de HELLP y otras microangiopatías. En: Medicina critica y terapia intensiva en obstetricia. 1a ed. México: Intersistemas editores, 2007;pp:241-7.

  13. Mockenhaupt FP, Bedu-Addo G, von Gaertner C, Boyé R, et al. Detection and clinical manifestation of placental malaria in southern Ghana. Malar J 2006;5:119.

  14. Rogerson SJ, Hviid L, Duffy PE, Leke RF, Taylor DW. Malaria in pregnancy: pathogenesis and immunity. Lancet Infect Dis 2007;7(2):105-17.

  15. Nosten F, McGready R, Simpson JA, Thwai, KL, et al. Effects of Plasmodium vivax malaria in pregnancy. Lancet 1999; 354(9178):546-9.

  16. Muehlenbachs A, Mutabingwa TK, Edmonds S, Fried M, Duffy PE. Hypertension and maternal-fetal conflict during placental malaria. PLoS Med 2006;3(11):e446.




2020     |     www.medigraphic.com